| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.09 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |